Savara (SVRA) Return on Sales (2013 - 2022)
Savara's (SVRA) quarterly Return on Sales came in at 404.17% in Q1 2022, down 24212.83% on a QoQ basis from 1.66% in Q4 2021.
Savara (SVRA) Return on Sales (2013 - 2022) Analysis & Trends
Savara (SVRA) has 8 years of Return on Sales data on file, last reported at 404.17% in Q1 2022.
- On a quarterly basis, Return on Sales changed N/A year-over-year to 404.17% in Q1 2022; TTM through Mar 2022 was 404.17%, a N/A change from a year earlier, with the FY2020 full-year figure at 98.03%, changed N/A from the prior year.
- Return on Sales for Q1 2022 stood at 404.17%, down from 1.66% in the prior quarter.
- Over the last five years, Return on Sales for SVRA reached as high as 0.44% in Q3 2020 and fell as low as 24825.92% in Q4 2020.
- Historically, Return on Sales has averaged 5066.0% across 3 years, with a median of 97.83% in 2021.
- On a YoY basis, Return on Sales climbed as much as 2482426 bps in 2021 and fell as far as 9739 bps in 2021.
- Year by year, Return on Sales stood at 24825.92% in 2020, then jumped by 100 bps to 1.66% in 2021, then tumbled by 24213 bps to 404.17% in 2022.
- Per Business Quant data, the three most recent Return on Sales figures were 404.17% in Q1 2022, 1.66% in Q4 2021, and 97.83% in Q3 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.00% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.00% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 0.00% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Savara | 1.24 Bn | 1.24 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | -404.17% |
| Dec 31, 2021 | -1.66% |
| Sep 30, 2021 | -97.83% |
| Dec 31, 2020 | -24,825.92% |
| Sep 30, 2020 | -0.44% |
| Sep 30, 2017 | -0.65% |
| Jun 30, 2017 | 1.22% |
| Mar 31, 2017 | -0.53% |
| Dec 31, 2016 | -0.07% |
| Sep 30, 2016 | -0.72% |
| Jun 30, 2016 | -4.87% |
| Mar 31, 2016 | -6.37% |
| Dec 31, 2015 | -2.25% |
| Mar 31, 2014 | -0.78% |
| Dec 31, 2013 | -0.43% |
| Jun 30, 2013 | -0.10% |
| Mar 31, 2013 | -0.14% |